The KKR-affiliated shareholder took 40 million of the 80 million shares sold at $12.50, the full $500 million it had flagged. The discount and the dilution are now fixed; the debt that covers most of the Devon purchase is still to come.
Crescent Energy's equity raise drew two kinds of buyer, and only one of them was new money from outside the company's shareholder register.
The Houston producer sold 80 million Class A shares at $12.50 late Thursday, raising $1 billion before fees. Exactly half went to Independence Energy Aggregator, the KKR-linked vehicle that already held roughly 7.9% of the Class A stock. It bought 40 million shares, or $500 million, the top of the amount it had signaled when the deal launched that morning. The other $500 million came from the rest of the market.
The cost of the discount
The $12.50 price sits 3.9% under Thursday's $13.01 close. Measured against the $13.47 close on Wednesday, before Crescent disclosed both the Devon Energy purchase and the stock sale, the discount widens to 7.2%.
Applied to 80 million shares, the discount to Thursday's close totals about $41 million, before underwriting fees. Against Wednesday's price, it is about $78 million.
A single early trade on Friday printed at $12.73, above the offering price.
How many more shares
Thursday's closing value of about $4.3 billion implies roughly 330 million shares outstanding. The new stock adds about 24% to that count. If underwriters use their 30-day option on 12 million more shares, worth $150 million, the increase approaches 28%. The shares are due to settle on Oct 13, 2026.
The $500 million bought by outside investors equals about 12% of Crescent's market value at Thursday's close.
What is still unfunded
The equity covers about $1 billion of a purchase Crescent values at roughly $3.85 billion after adjustments, against a headline price of $4.2 billion. That leaves about $2.85 billion, before fees, to come from cash and borrowing. Crescent has said it wants a balanced mix of debt and equity and is aiming for leverage near 1.0 times by the end of 2028.
The stock sale stands on its own. Should the Devon transaction fall through, Crescent said, the money will go to general corporate purposes, including paying down debt at its subsidiaries. The acquisition is targeted to close in the fourth quarter or early next year.
Between the launch and the pricing, the list of joint bookrunners grew from three banks to eight.
Two views
On one view, the financing came together without strain. It priced within 4% of a close that had already absorbed the news, and the anchor holder committed the most it had offered.
On another, the anchor order flatters the result. Outside demand amounted to $500 million, the price was 7.2% below where the stock stood before the announcement, and the larger debt financing has yet to be priced.
The debt terms
The size, rate and structure of the borrowing for the remaining $2.85 billion will determine where Crescent's leverage starts. How the shares trade against other oil producers after settlement on Oct 13, 2026 will show whether the market holds the $12.50 level. Devon, the seller, reports on Nov 5, 2026.